In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
India's health structure crumbles in front of Corona crisis, media is raising questions
The second wave of Corona in India has made the condition of health services in other major citie
A Russian court sentenced three people to death for helping Ukraine in its war against Russia. Th
Indian captain KL Rahul admitted that India's inability to score enough runs in the death overs c
Shardiya Navratri, the festival of worship of Adishakti, has started today. Navratri is a festiva
GIS 2023: 15 thousand crore investment proposal received from Sweden, will also invest in Film City
Industrial Development Minister Nand Gopal Gupta Nandi and PWD Minister Jitin Prasad, who went to
Congress leader Rahul Gandhi, who came to corner the BJP in favor of Congress candidate Pradeep J
Realme Narzo 30 launch with 48MP camera, will compete with Sony Xperia Ace 2
Realme Narzo 30 has been launched in the budget phone range. Currently, this phone has been launc
A Delhi court has acquitted Chief Minister Arvind Kejriwal, Deputy Chief Minister Manish Sisodia,
Violence has flared up in the West Bank following the death of two Israelis at the hands of a Pal
Corona Crisis: Center issued guidelines to take care of children who lost parents
Ram Mohan Mishra, Secretary, Ministry of Women and Child Development, wrote a letter on Wednesday
